Intradermal Injection of Oxytocin Aggravates Chloroquine-Induced Itch Responses

chloroquine itch nitric oxide oxytocin vasopressin-1a receptor

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 09 06 2019
accepted: 30 10 2019
entrez: 12 12 2019
pubmed: 12 12 2019
medline: 12 12 2019
Statut: epublish

Résumé

Oxytocin (OT), a hormone synthesized within the paraventricular nucleus and supraoptic nucleus of the hypothalamus, when given intracerebroventricularly, induces strong scratching behaviors. However, it is not clear whether intradermal injection (ID) of OT elicits itch sensation. Herein, we found that OT (0.02 mg/ml) did not elicit an itch-scratching response in mice but aggravated chloroquine (CQ, 3 mmol/L)-elicited scratching behavior. Similar to OT, arginine vasopressin (AVP, 0.02 mg/ml), which is structurally related to OT, also enhanced CQ-induced scratching behavior but did not directly induce scratching behavior in mice. Mechanistically, OT-mediated enhancement of CQ-induced scratching behavior was significantly suppressed by conivaptan (0.05 mg/ml), a vasopressin-1a receptor (V1AR) antagonist and 1,400 W (3 mg/kg), inhibitor of inducible nitric oxide synthase (iNOS), but not OT receptor (OTR) antagonist L-368,899 (0.05 mg/ml). Notably, conivaptan also directly decreased CQ-induced scratching. In conclusion, OT plays a role in CQ-induced scratching behavior

Identifiants

pubmed: 31824317
doi: 10.3389/fphar.2019.01380
pmc: PMC6881818
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1380

Informations de copyright

Copyright © 2019 Li, Sun, Zheng, Zong, Li, Meng, Li, Liu, Wang and Li.

Références

Neuroscience. 2015 Mar 19;289:417-28
pubmed: 25617653
Adv Exp Med Biol. 1998;449:347-58
pubmed: 10026824
Brain Res. 2003 Sep 5;983(1-2):13-22
pubmed: 12914962
Regul Pept. 2004 Aug 15;120(1-3):53-8
pubmed: 15177920
Brain Res. 2007 Jul 30;1160:20-9
pubmed: 17599811
Eur J Pharmacol. 2008 Apr 7;583(2-3):243-54
pubmed: 18280467
Int J Endocrinol. 2011;2011:350546
pubmed: 22190926
Lancet. 1989 Jul 22;2(8656):213
pubmed: 2568535
Prog Brain Res. 1983;60:101-14
pubmed: 6198686
Pain. 2006 Sep;124(1-2):50-8
pubmed: 16697529
Lupus. 2004;13(4):223-7
pubmed: 15176656
Eur J Pharmacol. 1990 Oct 2;187(1):1-8
pubmed: 2272347
J Clin Invest. 1998 Aug 1;102(3):595-605
pubmed: 9691096
Biomed Pharmacother. 2016 Dec;84:1367-1374
pubmed: 27802897
Pain. 2006 May;122(1-2):182-9
pubmed: 16527400
Physiol Rev. 2001 Apr;81(2):629-83
pubmed: 11274341
Regul Pept. 2006 Jul 15;135(1-2):85-90
pubmed: 16712978
Neuropeptides. 1994 Jul;27(1):63-74
pubmed: 7969820
Mol Pain. 2008 Jul 31;4:29
pubmed: 18667087
Biochem Soc Trans. 2007 Aug;35(Pt 4):737-41
pubmed: 17635137
Neurosci Lett. 1994 Mar 28;170(1):153-7
pubmed: 8041495
J Physiol. 2017 Jun 1;595(11):3651-3666
pubmed: 28217875
Cell. 2009 Dec 24;139(7):1353-65
pubmed: 20004959
Neurogastroenterol Motil. 2015 Jan;27(1):51-62
pubmed: 25346204
Neuropsychopharmacology. 2004 Mar;29(3):483-93
pubmed: 14647484
Comp Biochem Physiol C Toxicol Pharmacol. 2008 Nov;148(4):401-10
pubmed: 18417423
J Neurosci. 2010 Jun 16;30(24):8274-84
pubmed: 20554879
Science. 2008 Nov 7;322(5903):900-4
pubmed: 18988842
Neuron. 2008 May 22;58(4):639-50
pubmed: 18498743
J Physiol. 2008 Dec 1;586(23):5625-32
pubmed: 18845614
Peptides. 1992 Jan-Feb;13(1):17-25
pubmed: 1535707
Nat Neurosci. 2014 Feb;17(2):175-82
pubmed: 24473265
Pharmacol Biochem Behav. 1982 May;16(5):819-25
pubmed: 7089039
Curr Pharm Des. 2004;10(21):2643-8
pubmed: 15320751
Exp Dermatol. 2012 Jul;21(7):535-7
pubmed: 22583056
J Neurosci. 2007 Feb 28;27(9):2331-7
pubmed: 17329430
J Pharmacol Sci. 2009 Jan;109(1):38-43
pubmed: 19151540
J Pharmacol Sci. 2009 Jan;109(1):33-7
pubmed: 19151539
Pharmacol Res. 2005 Apr;51(4):329-36
pubmed: 15683746
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14153-6
pubmed: 18765804
J Comp Neurol. 1980 Dec 1;194(3):555-70
pubmed: 7451682
Pharmacol Biochem Behav. 2015 Jul;134:79-84
pubmed: 25957523
Trends Endocrinol Metab. 2000 Dec;11(10):406-10
pubmed: 11091117
Brain Res. 2002 Feb 15;927(2):204-7
pubmed: 11821014
Endocrinology. 1995 Apr;136(4):1509-15
pubmed: 7895660
Prog Brain Res. 1998;119:147-61
pubmed: 10074787
Biochem Soc Trans. 1995 Feb;23(1):21S
pubmed: 7758731
Sci Rep. 2015 Jul 10;5:11731
pubmed: 26159321
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
Pflugers Arch. 1994 Aug;428(1):51-9
pubmed: 7971161
Regul Pept. 2003 Oct 15;115(3):153-9
pubmed: 14556956

Auteurs

Rulong Li (R)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Hua Sun (H)

Department of the Sixth Internal Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Haotian Zheng (H)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Zhihua Zong (Z)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Shengnan Li (S)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Tingting Meng (T)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Jing Li (J)

Department of Pathology, Central Hospital of Zibo, Zibo, China.

Yunfang Liu (Y)

Center for Strategic Studies, Chinese Academy of Engineering, Beijing, China.

Chao Wang (C)

Department of Rehabilitation Medicine, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.

Jingxin Li (J)

Department of Physiology, School of Basic Medical Sciences, Shandong University Cheeloo Medical College, Jinan, China.

Classifications MeSH